The Burden of Pediatric Asthma

Giuliana Ferrante, Stefania La Grutta, Giuliana Ferrante, Stefania La Grutta

Abstract

Asthma is the most common chronic disease in children, imposing a consistent burden on health system. In recent years, prevalence of asthma symptoms became globally increased in children and adolescents, particularly in Low-Middle Income Countries (LMICs). Host (genetics, atopy) and environmental factors (microbial exposure, exposure to passive smoking and air pollution), seemed to contribute to this trend. The increased prevalence observed in metropolitan areas with respect to rural ones and, overall, in industrialized countries, highlighted the role of air pollution in asthma inception. Asthma accounts for 1.1% of the overall global estimate of "Disability-adjusted life years" (DALYs)/100,000 for all causes. Mortality in children is low and it decreased across Europe over recent years. Children from LMICs particularly suffer a disproportionately higher burden in terms of morbidity and mortality. Global asthma-related costs are high and are usually are classified into direct, indirect and intangible costs. Direct costs account for 50-80% of the total costs. Asthma is one of the main causes of hospitalization which are particularly common in children aged < 5 years with a prevalence that has been increased during the last two decades, mostly in LMICs. Indirect costs are usually higher than in older patients, including both school and work-related losses. Intangible costs are unquantifiable, since they are related to impairment of quality of life, limitation of physical activities and study performance. The implementation of strategies aimed at early detect asthma thus providing access to the proper treatment has been shown to effectively reduce the burden of the disease.

Keywords: asthma; burden; children; cost; epidemiology; morbidity; mortality; prevalence.

Figures

Figure 1
Figure 1
Prevalence of current wheezing in adolescents 13–14 years: data from ISAAC Phase III.
Figure 2
Figure 2
Socio-economic cost of childhood asthma: direct, indirect, and intangible costs.

References

    1. Soriano JB, Abajobir AA, Abate KH, Abera SF, Agrawal A, Ahmed MB, et al. . Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. (2017) 5:691–706. 10.1016/S2213-2600(17)30293-X
    1. Asher I, Pearce N. Global burden of asthma among children. Int J Tuberc Lung Dis. (2014) 18:1269–78. 10.5588/ijtld.14.0170
    1. Global Initiative for Asthma Global Strategy for Asthma Management and Prevention (2018). Available online at:
    1. Douwes J, Pearce N. Epidemiology of respiratory allergies and asthma. In: Ahrens W, Pigeot I, editors. Handjournal of Epidemiology. New York, NY: Springer; (2014). p. 2263–319.
    1. Asher M, Keil U, Anderson H, Beasley R, Crane J, Martinez F, et al. . International study of asthma and allergies in childhood (ISAAC): rationale and methods. Eur Respir J. (1995) 8:483–91. 10.1183/09031936.95.08030483
    1. Asher MI, Montefort S, Björkstén B, Lai CK, Strachan DP, Weiland SK, et al. . Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet (2006) 368:733–43. 10.1016/S0140-6736(06)69283-0
    1. Sestini P, De Sario M, Bugiani M, Bisanti L, Giannella G, Kaisermann D, et al. . Frequency of asthma and allergies in Italian children and adolescents: results from SIDRIA-2. Epidemiol Prev. (2005) 29:24–31.
    1. Ciccone G, Camarlengo A, Bugiani M, Dalmasso P, Faggiano F, Volante T, et al. . Asthma and respiratory symptoms in 6-7 yr old Italian children: gender, latitude, urbanization and socioeconomic factors. Eur Respir J. (1997) 10:1780–6.
    1. Uphoff EP, Bird PK, Antó JM, Basterrechea M, von Berg A, Bergström A, et al. . Variations in the prevalence of childhood asthma and wheeze in MeDALL cohorts in Europe. ERJ Open Res. (2017) 3:00150–2016. 10.1183/23120541.00150-2016
    1. Ellwood P, Asher MI, Billo NE, Bissell K, Chiang C-Y, Ellwood EM, et al. . The global asthma network rationale and methods for Phase I global surveillance: prevalence, severity, management and risk factors. Eur Respir J. (2017) 49:1601605. 10.1183/13993003.01605-2016
    1. Lai C, Beasley R, Crane J, Foliaki S, Shah J, Weiland S. Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax (2009) 64:476–83. 10.1136/thx.2008.106609
    1. Pearce N, Aït-Khaled N, Beasley R, Mallol J, Keil U, Mitchell E, et al. . Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax (2007) 62:758–66.
    1. Cruz ÁA, Stelmach R, Ponte EV. Asthma prevalence and severity in low-resource communities. Curr Opin Allergy Clin Immunol. (2017) 17:188–93. 10.1097/ACI.0000000000000360
    1. Galassi C, De Sario M, Biggeri A, Bisanti L, Chellini E, Ciccone G, et al. . Changes in prevalence of asthma and allergies among children and adolescents in Italy: 1994–2002. Pediatrics (2006) 117:34–42. 10.1542/peds.2004-2709
    1. Migliore E, Pearce N, Bugiani M, Galletti G, Biggeri A, Bisanti L, et al. . Prevalence of respiratory symptoms in migrant children to Italy: the results of SIDRIA-2 study. Allergy (2007) 62:293–300. 10.1111/j.1398-9995.2007.01238.x
    1. Nieuwenhuis MA, Siedlinski M, Berge M, Granell R, Li X, Niens M, et al. . Combining genomewide association study and lung eQTL analysis provides evidence for novel genes associated with asthma. Allergy (2016) 71:1712–20. 10.1111/all.12990
    1. Sarnowski C, Sugier P-E, Granell R, Jarvis D, Dizier M-H, Ege M, et al. . Identification of a new locus at 16q12 associated with time to asthma onset. J Allergy Clin Immunol. (2016) 138:1071–80. 10.1016/j.jaci.2016.03.018
    1. Schieck M, Schouten JP, Michel S, Suttner K, Toncheva AA, Gaertner VD, et al. . Doublesex and mab-3 related transcription factor 1 (DMRT1) is a sex-specific genetic determinant of childhood-onset asthma and is expressed in testis and macrophages. J Allergy Clin Immunol. (2016) 138:421–31. 10.1016/j.jaci.2015.12.1305
    1. McGeachie MJ, Yates KP, Zhou X, Guo F, Sternberg AL, Van Natta ML, et al. . Genetics and genomics of longitudinal lung function patterns in individuals with asthma. Am J Respir Crit Care Med. (2016) 194:1465–74. 10.1164/rccm.201602-0250OC
    1. Yang IV, Lozupone CA, Schwartz DA. The environment, epigenome, and asthma. J Allergy Clin Immunol. (2017) 140:14–23. 10.1016/j.jaci.2017.05.011
    1. Somineni HK, Zhang X, Myers JMB, Kovacic MB, Ulm A, Jurcak N, et al. . Ten-eleven translocation 1 (TET1) methylation is associated with childhood asthma and traffic-related air pollution. J Allergy Clin Immunol. (2016) 137:797–805. 10.1016/j.jaci.2015.10.021
    1. Simpson A, Tan VY, Winn J, Svensen M, Bishop CM, Heckerman DE, et al. . Beyond atopy: multiple patterns of sensitization in relation to asthma in a birth cohort study. Am J Respir Crit Care Med. (2010) 181:1200–6. 10.1164/rccm.200907-1101OC
    1. Stoltz DJ, Jackson DJ, Evans MD, Gangnon RE, Tisler CJ, Gern JE, et al. . Specific patterns of allergic sensitization in early childhood and asthma & rhinitis risk. Clin Exp Allergy (2013) 43:233–41. 10.1111/cea.12050
    1. Burbank AJ, Sood AK, Kesic MJ, Peden DB, Hernandez ML. Environmental determinants of allergy and asthma in early life. J Allergy Clin Immunol. (2017) 140:1–12. 10.1016/j.jaci.2017.05.010
    1. Rubner FJ, Jackson DJ, Evans MD, Gangnon RE, Tisler CJ, Pappas TE, et al. . Early life rhinovirus wheezing, allergic sensitization, and asthma risk at adolescence. J Allergy Clin Immunol. (2017) 139:501–7. 10.1016/j.jaci.2016.03.049
    1. Fishbein AB, Fuleihan RL. The hygiene hypothesis revisited: does exposure to infectious agents protect us from allergy? Curr Opin Pediatr. (2012) 24:98–102. 10.1097/MOP.0b013e32834ee57c
    1. Bacharier LB, Cohen R, Schweiger T, Yin-DeClue H, Christie C, Zheng J, et al. . Determinants of asthma after severe respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol. (2012) 130:91–100. 10.1016/j.jaci.2012.02.010
    1. Jackson DJ, Gangnon RE, Evans MD, Roberg KA, Anderson EL, Pappas TE, et al. . Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med. (2008) 178:667–72. 10.1164/rccm.200802-309OC
    1. Lemanske RF, Jackson DJ, Gangnon RE, Evans MD, Li Z, Shult PA, et al. . Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol. (2005) 116:571–7. 10.1016/j.jaci.2005.06.024
    1. Hansbro PM, Starkey MR, Mattes J, Horvat JC. Pulmonary immunity during respiratory infections in early life and the development of severe asthma. Ann Am Thorac Soc. (2014) 11:S297–302. 10.1513/AnnalsATS.201402-086AW
    1. Darveaux JI, Lemanske RF. Infection-related asthma. J Allergy Clin Immunol Pract. (2014) 2:658–63. 10.1016/j.jaip.2014.09.011
    1. Tatum AJ, Shapiro GG. The effects of outdoor air pollution and tobacco smoke on asthma. Immunol Allergy Clin. (2005) 25:15–30. 10.1016/j.iac.2004.09.003
    1. Rancière F, Bougas N, Viola M, Momas I. Early exposure to traffic-related air pollution, respiratory symptoms at 4 years of age, and potential effect modification by parental allergy, stressful family events, and sex: a prospective follow-up study of the PARIS Birth Cohort. Environ Health Perspect. (2017) 125:737–45. 10.1289/EHP239
    1. Gehring U, Wijga AH, Brauer M, Fischer P, de Jongste JC, Kerkhof M, et al. . Traffic-related air pollution and the development of asthma and allergies during the first 8 years of life. Am J Respir Crit Care Med. (2010) 181:596–603. 10.1164/rccm.200906-0858OC
    1. Mölter A, Simpson A, Berdel D, Brunekreef B, Custovic A, Cyrys J, et al. . A multicentre study of air pollution exposure and childhood asthma prevalence: the ESCAPE project. Eur Respir J. (2014) 45:610–24. 10.1183/09031936.00083614
    1. Gehring U, Wijga AH, Hoek G, Bellander T, Berdel D, Brüske I, et al. . Exposure to air pollution and development of asthma and rhinoconjunctivitis throughout childhood and adolescence: a population-based birth cohort study. Lancet Respir Med. (2015) 3:933–42. 10.1016/S2213-2600(15)00426-9
    1. Bowatte G, Lodge C, Lowe AJ, Erbas B, Perret J, Abramson MJ, et al. . The influence of childhood traffic-related air pollution exposure on asthma, allergy and sensitization: a systematic review and a meta-analysis of birth cohort studies. Allergy (2015) 70:245–56. 10.1111/all.12561
    1. Ferrante G, Antona R, Malizia V, Montalbano L, Corsello G, La Grutta S. Smoke exposure as a risk factor for asthma in childhood: a review of current evidence. Allergy Asthma Proc. (2014) 35:454–61. 10.2500/aap.2014.35.3789
    1. La Grutta S, Indinnimeo L, di Coste A, Ferrante G, Landi M, Pelosi U, et al. . Environmental risk factors and lung diseases in children: from guidelines to health effects. Early Hum Dev. (2013) 89:S59–62. 10.1016/j.earlhumdev.2013.07.025
    1. Ferrante G, Simoni M, Cibella F, Ferrara F, Liotta G, Malizia V, et al. . Third-hand smoke exposure and health hazards in children. Monaldi Arch Chest Dis. (2013) 79:38–43. 10.4081/monaldi.2013.108
    1. Ferkol TW, Farber HJ, La Grutta S, Leone FT, Marshall HM, Neptune E, et al. . Electronic cigarette use in youths: a position statement of the Forum of International Respiratory Societies. Eur Respir J. (2018) 51:1800278. 10.1183/13993003.00278-2018
    1. Kim SY, Sim S, Choi HG. Active, passive, and electronic cigarette smoking is associated with asthma in adolescents. Sci Rep. (2017) 7:17789. 10.1038/s41598-017-17958-y
    1. Schweitzer RJ, Wills TA, Tam E, Pagano I, Choi K. E-cigarette use and asthma in a multiethnic sample of adolescents. Prev Med. (2017) 105:226–31. 10.1016/j.ypmed.2017.09.023
    1. To T, Wang C, Guan J, McLimont S, Gershon AS. What is the lifetime risk of physician-diagnosed asthma in Ontario, Canada? Am J Respir Crit Care Med. (2010) 181:337–43. 10.1164/rccm.200907-1035OC
    1. Tai A, Tran H, Roberts M, Clarke N, Gibson A-M, Vidmar S, et al. . Outcomes of childhood asthma to the age of 50 years. J Allergy Clin Immunol. (2014) 133:1572–8. 10.1016/j.jaci.2013.12.1033
    1. Bateman ED, Reddel HK, van Zyl-Smit RN, Agusti A. The asthma–COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases? Lancet Respir Med. (2015) 3:719–28. 10.1016/S2213-2600(15)00254-4
    1. Bui DS, Lodge CJ, Burgess JA, Lowe AJ, Perret J, Bui MQ, et al. . Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life. Lancet Respir Med. (2018) 10.1016/S2213-2600(18)30100-0. [Epub ahead of print].
    1. Murray CJ. Summary Measures of Population Health: Concepts, Ethics, Measurement and Applications. Geneva: World Health Organization; (2002).
    1. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. . Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 380:2163–96. 10.1016/S0140-6736(12)61729-2
    1. Global Asthma Report 2014 Available at:
    1. Anderson H, Gupta R, Kapetanakis V, Asher M, Clayton T, Robertson C, et al. . International correlations between indicators of prevalence, hospital admissions and mortality for asthma in children. Int J Epidemiol. (2008) 37:573–82. 10.1093/ije/dyn039
    1. Gibson G, Loddenkemper R, Sibille Y, Lundbäck B. The European Lung White Journal: Respiratory Health and Disease in Europe. Sheffield, UK: European Respiratory Society; (2013).
    1. Levy M, Andrews R, Buckingham R, Evans H, Francis C, Houston R, et al. Why asthma still kills: the National Review of Asthma Deaths (NRAD). Royal College of Physcians; (2014).
    1. Nunes C, Pereira AM, Morais-Almeida M. Asthma costs and social impact. Asthma Res Pract. (2017) 3:1. 10.1186/s40733-016-0029-3
    1. Ferreira de Magalhães M, Amaral R, Pereira AM, Sá-Sousa A, Azevedo I, Azevedo LF, et al. . Cost of asthma in children: a nationwide, population-based, cost-of-illness study. Pediatr Allergy Immunol. (2017) 28:683–91. 10.1111/pai.12772
    1. Nunes C, Ladeira S. Asthma, from childhood to adulthood: a prospective 20-year longitudinal study of a cohort of asthmatics. J Investig Allergol Clin Immunol. (2002) 12:242–9. 10.1053/rmed.1999.076
    1. Akdis CA, Agache I. Global Atlas of Asthma. Zurich: European Academy of Allergy and Clinical Immunology; (2013).
    1. Sullivan PW, Ghushchyan V, Navaratnam P, Friedman HS, Kavati A, Ortiz B, et al. . National prevalence of poor asthma control and associated outcomes among school-aged children in the United States. J Allergy Clin Immunol Pract. (2018) 6:536–44. 10.1016/j.jaip.2017.06.039
    1. Braman SS. The global burden of asthma. Chest (2006) 130:4S−12S. 10.1378/chest.130.1_suppl.4S
    1. Selroos O, Kupczyk M, Kuna P, Lacwik P, Bousquet J, Brennan D, et al. . National and regional asthma programmes in Europe. Eur Respir Rev. (2015) 24:474–83. 10.1183/16000617.00008114
    1. Asher I, Haahtela T, Selroos O, Ellwood P, Ellwood E.Group GANS, others. Global Asthma Network survey suggests more national asthma strategies could reduce burden of asthma. Allergol Immunopathol. (2017) 45:105–14. 10.1016/j.aller.2016.10.013
    1. Genuneit J, Seibold A, Apfelbacher C, Konstantinou G, Koplin J, La Grutta S, et al. . “Overview of systematic reviews in allergy epidemiology (OSRAE)” of the EAACI interest group on epidemiology. overview of systematic reviews in allergy epidemiology. Allergy (2017) 72:849–56. 10.1111/all.13123
    1. Genuneit J, Seibold AM, Apfelbacher CJ, Konstantinou GN, Koplin JJ, Grutta S, et al. . The state of asthma epidemiology: an overview of systematic reviews and their quality. Clin Transl Allergy (2017) 7:12. 10.1186/s13601-017-0146-y

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner